• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Arrhythmia Monitoring Devices Market Share

    ID: MRFR/MED/5251-CR
    134 Pages
    Rahul Gotadki
    May 2019

    Arrhythmia Monitoring Devices Market Report Information By Device Type (Resting ECG, Event Monitor, Holter Monitor, Others), Application (Tachycardia, Bradycardia, Others), End User (Hospitals and Clinics, Others) and Region - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Arrhythmia Monitoring Devices Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Arrhythmia Monitoring Devices Market Share Analysis

    The Arrhythmia Monitoring Devices Market is a dynamic sector within the broader healthcare industry, which is evolving continuously due to the increasing prevalence of cardiovascular diseases and a greater focus on preventive healthcare. Firstly, product differentiation is a crucial factor in market share positioning. Innovations and technological improvements are constantly being made so that monitoring devices can be more different from each other depending on their accuracy levels. By doing this, companies can attract specific customer groups that require such products, not any other kind in the market. For example, some organizations are currently focusing on wearable devices that have real-time monitoring capabilities, while others are integrating AI for better arrhythmia detection. Secondly, strategic partnerships and collaborations are vital in gaining a competitive advantage as well as expanding market share. For instance, companies often forge partnerships with healthcare organizations, research institutions, or other industry participants to access their combined competencies. In addition, aggressive marketing and promotional activities undertaken by players in the market lead to improved brand visibility and customer awareness. By doing so, a strong presence is built that results in trust among end-users as well as healthcare providers, thereby influencing their purchase decisions. Effective marketing strategies involve taking part in medical conferences, educational programs, and online promotions through which a wider target audience can be reached. Additionally, pricing strategies play an essential role in market share positioning within the Arrhythmia Monitoring Devices Market. This may involve a discounted price that will enable a firm to gain a cost advantage over its competitors, thus attracting more customers. Furthermore, entering new markets forms part of market share positioning strategies where firms want to expand their geographical coverage into untapped territories, resulting in new customer types being acquired by them. This might necessitate compliance with local regulations and bureaucracy surrounding healthcare delivery systems while at the same time having products that meet regional standards. Moreover, continuous Research & Development (R&D) initiatives are necessary for competitive advantage maintenance in view of rapid technology changes and healthcare practices that have seen the need for continuous innovation to address emerging complexities.

    Market Summary

    The Global Arrhythmia Monitoring Devices Market is projected to grow from 5.6 USD Billion in 2024 to 10.7 USD Billion by 2032.

    Key Market Trends & Highlights

    Arrhythmia Monitoring Devices Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 6.07 percent from 2025 to 2032.
    • By 2035, the market valuation is anticipated to reach 10.7 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 5.6 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced monitoring technologies due to increasing prevalence of arrhythmias is a major market driver.

    Market Size & Forecast

    2024 Market Size 5.6 (USD Billion)
    2035 Market Size 10.7 (USD Billion)
    CAGR (2025-2035) 6.07%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Abbott Laboratories, BioTelemetry Inc., Fukuda Denshi Co. Ltd, Applied Cardiac Systems Inc., Medtronic plc, Nihon Kohden Corporation, Alive Cor Inc., Biotronik, GE Healthcare, Spacelabs Healthcare

    Market Trends

    Arrhythmia monitoring system has been gaining significance in recent years owing to the rising cases of heart diseases. The ease of FDA approvals, increasing adoption of low-cost electrocardiogram (ECG) devices, and the increasing geriatric population are some salient causes that can propel the industry in the coming period. In addition, the mounting cases of cardiac disorders are likely to favor market expansion in the assessment period.

     However, complications related to these devices may negatively affect the expansion of the arrhythmia monitoring devices market over the assessment period.

    Drivers

    Innovation in Product to Grow the Adoption of Device among Professionals

    The on-going technical development allowing remote monitoring of cardiac rhythm in patients is expected to be one of the most salient factors that can augment the market in the coming period.  The high accuracy and efficiency provided by arrhythmia detection is expected to surge its demand, thereby raising the market. Furthermore, the growing requirement for continuous cardiac rhythm monitoring in the emergency department is expected to augment the arrhythmia monitoring devices market size in the assessment period.

    Opportunities

    Growing Incidence of CVDs to Offer Market Expansion Opportunities

    Adoption of unhealthy diet such as; consumption of a sugar-rich diet, smoking, alcoholism, and higher adoption of a sedentary lifestyle are some of the crucial factors that can offer various expansion opportunities to the arrhythmia monitoring devices industry.

    Restraints

    Associated Complications can impede the market

    Despite the propelling factors, the market can witness hindrance in the coming period. The complications related to such devices along with the rise in recalls of arrhythmia monitoring devices can bring negative impact on the arrhythmia monitoring devices market share.

    Challenges

    Lack of Resources can pose a Severe Challenge to Grow the Market

    The market is predicted to experience a challenge due to the lack of expertise. In addition, some cardiac monitoring devices may have a negative impact on patients, which is another potent challenge that can restrict the market from growing.

    Cumulative Growth Analysis

    The market is projected to Show Steady Growth in the Assessment Timeframe

    The market for arrhythmia monitoring devices is expected to experience a notable expansion in the coming period owing to the increasing cases of CVDs along with the expansion of geriatric population.

    The increasing prevalence of cardiovascular diseases is driving the demand for advanced arrhythmia monitoring devices, which are essential for timely diagnosis and effective management of heart conditions.

    U.S. Food and Drug Administration (FDA)

    Arrhythmia Monitoring Devices Market Market Drivers

    Rising Awareness and Education

    Increased awareness regarding heart health and arrhythmias is driving the Global Arrhythmia Monitoring Devices Market Industry. Educational initiatives by health organizations and governments aim to inform the public about the risks associated with arrhythmias and the importance of early detection. Campaigns promoting heart health have led to more individuals seeking medical advice and monitoring solutions. This heightened awareness is likely to result in increased adoption of arrhythmia monitoring devices, as patients become more proactive in managing their health. Consequently, this trend is expected to bolster market growth significantly in the coming years.

    Increasing Geriatric Population

    The global demographic shift towards an aging population significantly influences the Global Arrhythmia Monitoring Devices Market Industry. Older adults are more susceptible to arrhythmias, necessitating continuous monitoring to prevent severe complications. According to the United Nations, the number of people aged 65 and older is projected to reach 1.5 billion by 2050. This demographic trend underscores the need for effective arrhythmia management solutions. As healthcare systems adapt to cater to this growing population, the demand for monitoring devices is likely to surge, contributing to a compound annual growth rate of 6.07 percent from 2025 to 2035.

    Rising Prevalence of Cardiac Disorders

    The increasing incidence of cardiac disorders globally is a primary driver of the Global Arrhythmia Monitoring Devices Market Industry. As cardiovascular diseases continue to rise, the demand for effective monitoring solutions becomes more pronounced. For instance, the World Health Organization indicates that cardiovascular diseases are the leading cause of death worldwide, accounting for approximately 32 percent of all deaths. This alarming trend necessitates advanced monitoring devices to manage arrhythmias effectively. The market is projected to reach 5.6 USD Billion in 2024, reflecting the urgent need for innovative solutions to address this growing health crisis.

    Regulatory Support and Reimbursement Policies

    Supportive regulatory frameworks and favorable reimbursement policies are vital drivers of the Global Arrhythmia Monitoring Devices Market Industry. Governments and health authorities are increasingly recognizing the importance of arrhythmia monitoring in improving patient outcomes. As a result, they are implementing policies that facilitate the approval and reimbursement of innovative monitoring devices. This regulatory support encourages manufacturers to invest in research and development, leading to the introduction of advanced technologies. Such initiatives not only enhance market accessibility but also stimulate growth, as healthcare providers are more likely to adopt devices that are financially supported by insurance plans.

    Technological Advancements in Monitoring Devices

    Technological innovations play a crucial role in shaping the Global Arrhythmia Monitoring Devices Market Industry. The development of advanced wearable devices, mobile health applications, and remote monitoring systems enhances patient engagement and enables real-time data collection. For example, devices equipped with artificial intelligence algorithms can analyze heart rhythms more accurately, leading to timely interventions. These advancements not only improve patient outcomes but also drive market growth. As the industry evolves, the integration of telemedicine and digital health technologies is expected to further propel the market, potentially doubling its value to 10.7 USD Billion by 2035.

    Market Segment Insights

    Arrhythmia Monitoring Devices

    Based on type, the global market for cardiac arrhythmia monitoring devices is segmented into event monitor, resting ECG, implantable cardiac monitor (ICM), mobile cardiac telemetry (MCT) devices, Holter monitor, and others. Holter monitor is predicted to gain prominence in the coming period due to the introduction of wireless wearable technology in the device.

    Arrhythmia Monitoring Devices

    The Tachycardia Segment to Grow Significantly

    Based on application, the global market for arrhythmia monitoring devices market is segmented into bradycardia, tachycardia, atrial fibrillation (A-fib), premature ventricular contractions (PVC), ventricular fibrillation (V-fib), conduction disorders, and others. Among all, the tachycardia segment is expected to grow significantly during the forecast period.

    Arrhythmia Monitoring Devices

    Hospitals and Clinics to Dominate the Market

    Based on type, the global market for arrhythmia monitoring devices market is segmented into ambulatory surgery centers (ASC), diagnostic centers, hospitals & clinics, home care settings, and others. The hospitals and clinics segment accounted for a market value of USD 1,740.0 Million in 2018.

    Get more detailed insights about Arrhythmia Monitoring Devices Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Arrhythmia Monitoring Devices Market market include

    Industry Developments

    • Q2 2024: Medtronic receives FDA approval for LINQ II™ insertable cardiac monitor for pediatric patients Medtronic announced FDA approval for its LINQ II™ insertable cardiac monitor to be used in pediatric patients, expanding its arrhythmia monitoring device portfolio for younger populations.
    • Q2 2024: Abbott launches new Jot Dx™ insertable cardiac monitor in the U.S. Abbott introduced the Jot Dx™ insertable cardiac monitor in the United States, designed to provide advanced arrhythmia detection and remote monitoring capabilities for clinicians and patients.
    • Q3 2024: Boston Scientific announces acquisition of Preventice Solutions Boston Scientific completed the acquisition of Preventice Solutions, a company specializing in remote cardiac monitoring and wearable arrhythmia detection devices, strengthening its position in the arrhythmia monitoring sector.
    • Q3 2024: iRhythm Technologies appoints new CEO Quentin Blackford iRhythm Technologies, a leader in ambulatory cardiac monitoring, announced the appointment of Quentin Blackford as Chief Executive Officer to drive growth and innovation in arrhythmia monitoring solutions.
    • Q4 2024: Philips launches next-generation wearable ECG patch for arrhythmia detection Philips unveiled a new wearable ECG patch designed for continuous arrhythmia monitoring, offering improved comfort and data accuracy for patients in ambulatory settings.
    • Q4 2024: Biotronik receives CE Mark for BioMonitor IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BioMonitor IV implantable cardiac monitor, enabling expanded use of the device for arrhythmia detection in Europe.
    • Q1 2025: Hill-Rom Holdings opens new cardiac monitoring device manufacturing facility in Texas Hill-Rom Holdings inaugurated a new manufacturing facility in Texas dedicated to the production of advanced cardiac arrhythmia monitoring devices, aiming to meet rising demand in North America.
    • Q1 2025: Vivaquant raises $25M Series B to expand arrhythmia monitoring device development Vivaquant secured $25 million in Series B funding to accelerate the development and commercialization of its next-generation arrhythmia monitoring devices.
    • Q2 2025: GE Healthcare partners with Mindray Medical to co-develop AI-powered arrhythmia monitoring solutions GE Healthcare and Mindray Medical announced a strategic partnership to jointly develop artificial intelligence-powered arrhythmia monitoring devices for global markets.
    • Q2 2025: iRhythm Technologies completes $100M public offering to fund arrhythmia monitoring device R&D iRhythm Technologies completed a $100 million public offering, with proceeds earmarked for research and development of new ambulatory arrhythmia monitoring devices.
    • Q3 2025: Boston Scientific receives FDA clearance for LUX-Dx™ insertable cardiac monitor Boston Scientific announced FDA clearance for its LUX-Dx™ insertable cardiac monitor, expanding its portfolio of devices for long-term arrhythmia detection.
    • Q3 2025: Abbott partners with Schiller AG to distribute arrhythmia monitoring devices in Asia-Pacific Abbott entered into a distribution partnership with Schiller AG to expand the reach of its arrhythmia monitoring devices across the Asia-Pacific region.

    Key Players

      • BioTelemetry Inc. (US)
      • Fukuda Denshi Co. Ltd (Japan)
      • Applied Cardiac Systems Inc. (US)
      • Nihon Kohden Corporation (Japan)
      • Alive Cor Inc. (US)
      • Biotronik (Germany)
      • GE Healthcare (US)
      • Spacelabs Healthcare (US)

    Future Outlook

    Arrhythmia Monitoring Devices Market Future Outlook

    The Arrhythmia Monitoring Devices Market is projected to grow at a 6.07% CAGR from 2024 to 2032, driven by technological advancements, increasing prevalence of arrhythmias, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven analytics for real-time arrhythmia detection.
    • Expand telehealth solutions for remote patient monitoring.
    • Invest in wearable devices with enhanced data integration capabilities.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements in technology and increased demand.

    Market Segmentation

    Key Players

    • Spacelabs Healthcare (US)
    • GE Healthcare (US)
    • Biotronik (Germany)
    • Alive Cor Inc. (US)
    • Nihon Kohden Corporation (Japan)
    • Medtronic plc (Ireland)
    • Applied Cardiac Systems Inc. (US)
    • Fukuda Denshi Co. Ltd (Japan)
    • BioTelemetry Inc. (US)
    • Abbott Laboratories (US)

    Arrhythmia Monitoring Devices Market Industry Developments

    • Q2 2024: Medtronic receives FDA approval for LINQ II™ insertable cardiac monitor for pediatric patients Medtronic announced FDA approval for its LINQ II™ insertable cardiac monitor to be used in pediatric patients, expanding its arrhythmia monitoring device portfolio for younger populations.
    • Q2 2024: Abbott launches new Jot Dx™ insertable cardiac monitor in the U.S. Abbott introduced the Jot Dx™ insertable cardiac monitor in the United States, designed to provide advanced arrhythmia detection and remote monitoring capabilities for clinicians and patients.
    • Q3 2024: Boston Scientific announces acquisition of Preventice Solutions Boston Scientific completed the acquisition of Preventice Solutions, a company specializing in remote cardiac monitoring and wearable arrhythmia detection devices, strengthening its position in the arrhythmia monitoring sector.
    • Q3 2024: iRhythm Technologies appoints new CEO Quentin Blackford iRhythm Technologies, a leader in ambulatory cardiac monitoring, announced the appointment of Quentin Blackford as Chief Executive Officer to drive growth and innovation in arrhythmia monitoring solutions.
    • Q4 2024: Philips launches next-generation wearable ECG patch for arrhythmia detection Philips unveiled a new wearable ECG patch designed for continuous arrhythmia monitoring, offering improved comfort and data accuracy for patients in ambulatory settings.
    • Q4 2024: Biotronik receives CE Mark for BioMonitor IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BioMonitor IV implantable cardiac monitor, enabling expanded use of the device for arrhythmia detection in Europe.
    • Q1 2025: Hill-Rom Holdings opens new cardiac monitoring device manufacturing facility in Texas Hill-Rom Holdings inaugurated a new manufacturing facility in Texas dedicated to the production of advanced cardiac arrhythmia monitoring devices, aiming to meet rising demand in North America.
    • Q1 2025: Vivaquant raises $25M Series B to expand arrhythmia monitoring device development Vivaquant secured $25 million in Series B funding to accelerate the development and commercialization of its next-generation arrhythmia monitoring devices.
    • Q2 2025: GE Healthcare partners with Mindray Medical to co-develop AI-powered arrhythmia monitoring solutions GE Healthcare and Mindray Medical announced a strategic partnership to jointly develop artificial intelligence-powered arrhythmia monitoring devices for global markets.
    • Q2 2025: iRhythm Technologies completes $100M public offering to fund arrhythmia monitoring device R&D iRhythm Technologies completed a $100 million public offering, with proceeds earmarked for research and development of new ambulatory arrhythmia monitoring devices.
    • Q3 2025: Boston Scientific receives FDA clearance for LUX-Dx™ insertable cardiac monitor Boston Scientific announced FDA clearance for its LUX-Dx™ insertable cardiac monitor, expanding its portfolio of devices for long-term arrhythmia detection.
    • Q3 2025: Abbott partners with Schiller AG to distribute arrhythmia monitoring devices in Asia-Pacific Abbott entered into a distribution partnership with Schiller AG to expand the reach of its arrhythmia monitoring devices across the Asia-Pacific region.

    Report Scope

    Report Attribute/Metric Details
      Market Size 2032   USD 8.20 Billion
      CAGR   9.32% (2024-2032)
      Base Year 2023
      Forecast Period   2024-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Device Type, Application, End User, Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott Laboratories (US), BioTelemetry Inc. (US), Fukuda Denshi Co. Ltd (Japan), Applied Cardiac Systems Inc. (US), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Alive Cor Inc. (US), Biotronik (Germany), GE Healthcare (US), Spacelabs Healthcare (US)
      Key Market Opportunities   Growing Incidence of CVDs to Offer Market Expansion Opportunities
      Key Market Drivers   Innovation in Product to Grow the Adoption of Device among Professionals

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    What would be the worth of the arrhythmia monitoring devices market by 2032?

    The arrhythmia monitoring devices market would be worth USD 8.20 Billion by 2032.

    At what speed the arrhythmia monitoring devices market would grow during the forecast period of 2024-2032?

    The arrhythmia monitoring devices market is showing signs of 9.32% CAGR during the forecast period of 2024-2032.

    What could prevent the arrhythmia monitoring devices market from having a normal growth?

    The arrhythmia monitoring devices market growth can be deterred by the high cost of the remote monitoring system and notable product recalls.

    Which end user segment would influence the arrhythmia monitoring devices market the most?

    The hospitals & clinics segment would dominate the arrhythmia monitoring devices market.

    Which regional arrhythmia monitoring devices market would dominate the global market?

    The Americas have the chance to rule the arrhythmia monitoring devices market.

    1. List of Tables and Figures
      1. TABLE
      2. 1 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      3. MILLION) 33
      4. TABLE 2 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR RESTING
      5. ECG, BY REGION, 2020–2027 (USD MILLION) 34
      6. TABLE 3 GLOBAL ARRHYTHMIA
      7. MONITORING DEVICES MARKET FOR EVENT MONITORS, BY REGION, 2020–2027 (USD MILLION)
      8. 35
      9. TABLE 4 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR IMPLANTABLE
      10. CARDIAC MONITORS (ICM), BY REGION,
      11. 2020–2027 (USD MILLION) 36
      12. TABLE
      13. 5 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR HOLTER MONITORS, BY REGION, 2020–2027
      14. (USD MILLION) 37
      15. TABLE 6 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR
      16. MOBILE CARDIAC TELEMETRY (MCT) DEVICES, BY REGION,
      17. 2020–2027 (USD
      18. MILLION) 38
      19. TABLE 7 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      20. 2020–2027 (USD MILLION) 40
      21. TABLE 8 GLOBAL ARRHYTHMIA MONITORING
      22. DEVICES MARKET FOR TACHYCARDIA, BY REGION, 2020–2027 (USD MILLION) 41
      23. TABLE
      24. 9 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR BRADYCARDIA, BY REGION, 2020–2027
      25. (USD MILLION) 42
      26. TABLE 10 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET
      27. FOR ATRIAL FIBRILLATION (A-FIB), BY REGION,
      28. 2020–2027 (USD MILLION)
      29. 43
      30. TABLE 11 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR VENTRICULAR
      31. FIBRILLATION (V-FIB), BY REGION,
      32. 2020–2027 (USD MILLION) 44
      33. TABLE
      34. 12 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR PREMATURE VENTRICULAR CONTRACTIONS
      35. (PVC),
      36. BY REGION, 2020–2027 (USD MILLION) 45
      37. TABLE 13
      38. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR CONDUCTION DISORDERS, BY REGION,
      39. 2020–2027 (USD MILLION) 46
      40. TABLE 14 GLOBAL ARRHYTHMIA MONITORING
      41. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 48
      42. TABLE 15
      43. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR HOSPITALS AND CLINICS, BY REGION,
      44. 2020–2027 (USD MILLION) 49
      45. TABLE 16 GLOBAL ARRHYTHMIA MONITORING
      46. DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION)
      47. 50
      48. TABLE 17 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET FOR HOMECARE SETTINGS,
      49. BY REGION, 2020–2027 (USD MILLION) 51
      50. TABLE 18 GLOBAL ARRHYTHMIA
      51. MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS (ASC), BY REGION,
      52. 2020–2027
      53. (USD MILLION) 52
      54. TABLE 19 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET,
      55. BY REGION, 2020–2027 (USD MILLION) 54
      56. TABLE 20 AMERICAS: ARRHYTHMIA
      57. MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 56
      58. TABLE
      59. 21 AMERICAS: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027
      60. (USD MILLION) 56
      61. TABLE 22 AMERICAS: ARRHYTHMIA MONITORING DEVICES MARKET,
      62. BY APPLICATION, 2020–2027 (USD MILLION) 57
      63. TABLE 23 AMERICAS: ARRHYTHMIA
      64. MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 57
      65. TABLE
      66. 24 NORTH AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027
      67. (USD MILLION) 58
      68. TABLE 25 NORTH AMERICA: ARRHYTHMIA MONITORING DEVICES
      69. MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 59
      70. TABLE 26 NORTH
      71. AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD
      72. MILLION) 59
      73. TABLE 27 NORTH AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET,
      74. BY END USER, 2020–2027 (USD MILLION) 60
      75. TABLE 28 US: ARRHYTHMIA
      76. MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 60
      77. TABLE
      78. 29 US: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD
      79. MILLION) 61
      80. TABLE 30 US: ARRHYTHMIA MONITORING DEVICES MARKET, BY END
      81. USER, 2020–2027 (USD MILLION) 61
      82. TABLE 31 CANADA: ARRHYTHMIA MONITORING
      83. DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 62
      84. TABLE
      85. 32 CANADA: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027
      86. (USD MILLION) 63
      87. TABLE 33 CANADA: ARRHYTHMIA MONITORING DEVICES MARKET,
      88. BY END USER, 2020–2027 (USD MILLION) 63
      89. TABLE 34 LATIN AMERICA:
      90. ARRHYTHMIA MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
      91. 64
      92. TABLE 35 LATIN AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE
      93. TYPE, 2020–2027 (USD MILLION) 65
      94. TABLE 36 LATIN AMERICA: ARRHYTHMIA
      95. MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65
      96. TABLE
      97. 37 LATIN AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027
      98. (USD MILLION) 66
      99. TABLE 38 BRAZIL: ARRHYTHMIA MONITORING DEVICES MARKET,
      100. BY DEVICE TYPE, 2020–2027 (USD MILLION) 66
      101. TABLE 39 BRAZIL: ARRHYTHMIA
      102. MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67
      103. TABLE
      104. 40 BRAZIL: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      105. MILLION) 67
      106. TABLE 41 REST OF LATIN AMERICA: ARRHYTHMIA MONITORING DEVICES
      107. MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 68
      108. TABLE 42 REST
      109. OF LATIN AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027
      110. (USD MILLION) 69
      111. TABLE 43 REST OF LATIN AMERICA: ARRHYTHMIA MONITORING
      112. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 69
      113. TABLE 44
      114. EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
      115. 71
      116. TABLE 45 EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE,
      117. 2020–2027 (USD MILLION) 71
      118. TABLE 46 EUROPE: ARRHYTHMIA MONITORING
      119. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72
      120. TABLE
      121. 47 EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      122. MILLION) 72
      123. TABLE 48 WESTERN EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET,
      124. BY COUNTRY, 2020–2027 (USD MILLION) 73
      125. TABLE 49 WESTERN EUROPE:
      126. ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
      127. 74
      128. TABLE 50 WESTERN EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      129. 2020–2027 (USD MILLION) 74
      130. TABLE 51 WESTERN EUROPE: ARRHYTHMIA MONITORING
      131. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 75
      132. TABLE 52
      133. GERMANY: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      134. MILLION) 75
      135. TABLE 53 GERMANY: ARRHYTHMIA MONITORING DEVICES MARKET, BY
      136. APPLICATION, 2020–2027 (USD MILLION) 76
      137. TABLE 54 GERMANY: ARRHYTHMIA
      138. MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 76
      139. TABLE
      140. 55 UK: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      141. MILLION) 77
      142. TABLE 56 UK: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      143. 2020–2027 (USD MILLION) 78
      144. TABLE 57 UK: ARRHYTHMIA MONITORING DEVICES
      145. MARKET, BY END USER, 2020–2027 (USD MILLION) 78
      146. TABLE 58 FRANCE:
      147. ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
      148. 79
      149. TABLE 59 FRANCE: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      150. 2020–2027 (USD MILLION) 80
      151. TABLE 60 FRANCE: ARRHYTHMIA MONITORING
      152. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 80
      153. TABLE 61
      154. ITALY: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      155. MILLION) 81
      156. TABLE 62 ITALY: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      157. 2020–2027 (USD MILLION) 82
      158. TABLE 63 ITALY: ARRHYTHMIA MONITORING
      159. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 82
      160. TABLE 64
      161. SPAIN: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      162. MILLION) 83
      163. TABLE 65 SPAIN: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      164. 2020–2027 (USD MILLION) 84
      165. TABLE 66 SPAIN: ARRHYTHMIA MONITORING
      166. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 84
      167. TABLE 67
      168. REST OF WESTERN EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027
      169. (USD MILLION) 85
      170. TABLE 68 REST OF WESTERN EUROPE: ARRHYTHMIA MONITORING
      171. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86
      172. TABLE
      173. 69 REST OF WESTERN EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027
      174. (USD MILLION) 86
      175. TABLE 70 EASTERN EUROPE: ARRHYTHMIA MONITORING DEVICES
      176. MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 87
      177. TABLE 71 EASTERN
      178. EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD
      179. MILLION) 88
      180. TABLE 72 EASTERN EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET,
      181. BY END USER, 2020–2027 (USD MILLION) 88
      182. TABLE 73 ASIA-PACIFIC: ARRHYTHMIA
      183. MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
      184. TABLE
      185. 74 ASIA-PACIFIC: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027
      186. (USD MILLION) 90
      187. TABLE 75 ASIA-PACIFIC: ARRHYTHMIA MONITORING DEVICES
      188. MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91
      189. TABLE 76 ASIA-PACIFIC:
      190. ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
      191. 91
      192. TABLE 77 JAPAN: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE,
      193. 2020–2027 (USD MILLION) 92
      194. TABLE 78 JAPAN: ARRHYTHMIA MONITORING
      195. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
      196. TABLE
      197. 79 JAPAN: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      198. MILLION) 93
      199. TABLE 80 CHINA: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE
      200. TYPE, 2020–2027 (USD MILLION) 94
      201. TABLE 81 CHINA: ARRHYTHMIA MONITORING
      202. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95
      203. TABLE
      204. 82 CHINA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      205. MILLION) 95
      206. TABLE 83 INDIA: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE
      207. TYPE, 2020–2027 (USD MILLION) 96
      208. TABLE 84 INDIA: ARRHYTHMIA MONITORING
      209. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
      210. TABLE
      211. 85 INDIA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      212. MILLION) 97
      213. TABLE 86 AUSTRALIA: ARRHYTHMIA MONITORING DEVICES MARKET,
      214. BY DEVICE TYPE, 2020–2027 (USD MILLION) 98
      215. TABLE 87 AUSTRALIA: ARRHYTHMIA
      216. MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99
      217. TABLE
      218. 88 AUSTRALIA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027
      219. (USD MILLION) 99
      220. TABLE 89 SOUTH KOREA: ARRHYTHMIA MONITORING DEVICES MARKET,
      221. BY DEVICE TYPE, 2020–2027 (USD MILLION) 100
      222. TABLE 90 SOUTH KOREA:
      223. ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
      224. 101
      225. TABLE 91 SOUTH KOREA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END
      226. USER, 2020–2027 (USD MILLION) 101
      227. TABLE 92 REST OF ASIA-PACIFIC:
      228. ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
      229. 102
      230. TABLE 93 REST OF ASIA-PACIFIC: ARRHYTHMIA MONITORING DEVICES MARKET,
      231. BY APPLICATION, 2020–2027 (USD MILLION) 103
      232. TABLE 94 REST OF ASIA-PACIFIC:
      233. ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
      234. 103
      235. TABLE 95 MIDDLE EAST & AFRICA: ARRHYTHMIA MONITORING DEVICES MARKET,
      236. BY REGION, 2020–2027 (USD MILLION) 105
      237. TABLE 96 MIDDLE EAST &
      238. AFRICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      239. MILLION) 105
      240. TABLE 97 MIDDLE EAST & AFRICA: ARRHYTHMIA MONITORING
      241. DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
      242. TABLE
      243. 98 MIDDLE EAST & AFRICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER,
      244. 2020–2027 (USD MILLION) 106
      245. TABLE 99 MIDDLE EAST: ARRHYTHMIA MONITORING
      246. DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION) 107
      247. TABLE
      248. 100 MIDDLE EAST: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020–2027
      249. (USD MILLION) 108
      250. TABLE 101 MIDDLE EAST: ARRHYTHMIA MONITORING DEVICES
      251. MARKET, BY END USER, 2020–2027 (USD MILLION) 108
      252. TABLE 102 AFRICA:
      253. ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD MILLION)
      254. 109
      255. TABLE 103 AFRICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION,
      256. 2020–2027 (USD MILLION) 110
      257. TABLE 104 AFRICA: ARRHYTHMIA MONITORING
      258. DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION) 110
      259. 14
    2. List of Tables and Figures
      1. FIGURE 1 MARKET SYNOPSIS 14
      2. FIGURE
      3. 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET 15
      4. FIGURE
      5. 3 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY DEVICE TYPE, 2020 (%) 15
      6. FIGURE
      7. 4 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET, BY DEVICE TYPE, 2020–2027 (USD
      8. MILLION) 15
      9. FIGURE 5 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET SHARE,
      10. BY APPLICATION, 2020 (%) 16
      11. FIGURE 6 GLOBAL ARRHYTHMIA MONITORING DEVICES
      12. MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 16
      13. FIGURE 7 GLOBAL
      14. ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY END USER, 2020 (%) 16
      15. FIGURE
      16. 8 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD
      17. MILLION) 17
      18. FIGURE 9 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET: MARKET
      19. STRUCTURE 18
      20. FIGURE 10 RESEARCH PROCESS OF MRFR 19
      21. FIGURE 11
      22. TOP-DOWN & BOTTOM-UP APPROACH 22
      23. FIGURE 12 MARKET DYNAMICS: ANALYSIS
      24. OF THE GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET 23
      25. FIGURE 13 DRIVERS
      26. IMPACT ANALYSIS: GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET 25
      27. FIGURE
      28. 14 RESTRAINTS IMPACT ANALYSIS: GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET 26
      29. FIGURE
      30. 15 VALUE CHAIN: GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET 28
      31. FIGURE
      32. 16 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET
      33. 30
      34. FIGURE 17 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET SHARE, BY DEVICE
      35. TYPE, 2020 (%) 32
      36. FIGURE 18 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET,
      37. BY DEVICE TYPE, 2020 AND 2027 (USD MILLION) 32
      38. FIGURE 19 GLOBAL ARRHYTHMIA
      39. MONITORING DEVICES MARKET SHARE, BY APPLICATION, 2020 (%) 39
      40. FIGURE 20
      41. GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2020 AND 2027 (USD
      42. MILLION) 40
      43. FIGURE 21 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET SHARE,
      44. BY END USER, 2020 (%) 47
      45. FIGURE 22 GLOBAL ARRHYTHMIA MONITORING DEVICES
      46. MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 47
      47. FIGURE 23 GLOBAL ARRHYTHMIA
      48. MONITORING DEVICES MARKET SHARE, BY REGION, 2020 (%) 53
      49. FIGURE 24 GLOBAL
      50. ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 53
      51. FIGURE
      52. 25 AMERICAS: ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION, 2020 AND 2027 55
      53. FIGURE
      54. 26 NORTH AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY COUNTRY, 2020 AND 2027
      55. 58
      56. FIGURE 27 LATIN AMERICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY COUNTRY,
      57. 2020 AND 2027 64
      58. FIGURE 28 EUROPE: ARRHYTHMIA MONITORING DEVICES MARKET,
      59. BY REGION, 2020 AND 2027 70
      60. FIGURE 29 WESTERN EUROPE: ARRHYTHMIA MONITORING
      61. DEVICES MARKET, BY COUNTRY, 2020 AND 2027 73
      62. FIGURE 30 ASIA-PACIFIC: ARRHYTHMIA
      63. MONITORING DEVICES MARKET, BY COUNTRY, 2020 AND 2027 89
      64. FIGURE 31 MIDDLE
      65. EAST & AFRICA: ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION, 2020 AND 2027
      66. 104
      67. FIGURE 32 GLOBAL ARRHYTHMIA MONITORING DEVICES MARKET SHARE ANALYSIS,
      68. 2020 (%) 111
      69.  

    Arrhythmia Monitoring Devices Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials